Ocean Biomedical, Inc. (OCEA)
OTCMKTS · Delayed Price · Currency is USD
0.0009
-0.0001 (-10.00%)
At close: Mar 19, 2026
Ocean Biomedical Market Cap
Ocean Biomedical has a market cap or net worth of $209.13 thousand as of March 20, 2026. Its market cap has decreased by -98.38% in one year.
Market Cap
209.13K
Enterprise Value
15.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 8, 2021, Ocean Biomedical's market cap has decreased from 105.68M to 209.13K, a decrease of -99.80%. That is a compound annual growth rate of -76.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 209.13K | 80.00% |
| Dec 31, 2025 | 116.18K | -99.40% |
| Dec 31, 2024 | 19.28M | -14.29% |
| Dec 29, 2023 | 22.50M | -79.59% |
| Dec 30, 2022 | 110.24M | 4.10% |
| Dec 31, 2021 | 105.89M | 0.20% |
| Nov 8, 2021 | 105.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 423.01K |
| Actavia Life Sciences | 385.91K |
| Regenerative Medical Technology Group | 375.77K |
| Altamira Therapeutics | 342.93K |
| Ampio Pharmaceuticals | 326.47K |
| Helix BioMedix | 224.71K |
| Endonovo Therapeutics | 180.76K |
| CNBX Pharmaceuticals | 168.87K |